Remote Clinical Monitoring After Robotic Distal Pancreatectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorJessa Hospital

About this trial

This feasibility trial has three main objectives:

* To investigate the impact of the transmural care pathway TOTeM on the Length of Stay (LOS) for patients undergoing robotic distal pancreatectomy. * To investigate the feasibility of the implementation of TOTeM for patients undergoing robotic distal pancreatic surgery, we will measure the recruitment rate by tracking the number of eligible patients who are approached for participation, the percentage who consent to join the study over a specified time period, and the adherence rate which describes how well participants follow the study protocol including the prescribed interventions or follow-up assessments. * Assessment of the potential changes in medical costs and outcomes for the purpose of performing a cost-effectiveness analysis from a hospital and patient perspective.

Eligibility criteria

Qualifiers

18-75 years old

Competent to provide informed consent

Fluent in Dutch

Cognitively capable of understanding and engaging with the study

Disqualifiers

Extended left pancreatectomy

Spleen-preserving procedure

Residing in a nursing home

Patients who are deemed unsuitable for the study by the physician based on clinical evaluation

Trial design

Treatments tested in this trial

  • Remote clinical monitoring

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Jessa Hospital

Lead sponsor